Grifols Approves IPO for US Biopharma Business

Grifols, a global healthcare company, has approved an initial public offering (IPO) for a segment of its biopharma business located in the United States, following earlier considerations.

24 Mar, 21:11 — 24 Mar, 21:11

Post Share

Sources

Showing 1 of 4 sources

ReutersVery High138d ago

Grifols approves IPO of its US biopharma business - Reuters

Grifols approves IPO of its US biopharma business Reuters

Read full article →

Coverage Timeline

First report: Reuters · 24 Mar, 21:11|Full coverage: 4 · 1h|Window: 1h

Left-leaningCenterRight-leaning

Reuters24 Mar, 21:11First to report

PERSPECTA

PERSPECTA

Grifols Approves IPO for US Biopharma Business

Sources

Grifols approves IPO of its US biopharma business - Reuters

Coverage Timeline

Grifols approves IPO of its US biopharma business - Reuters

Grifols considers IPO of part of its US biopharma business

Grifols sacará bolsa su negocio de Biopharma en Estados Unidos

Grifols prepara la salida a bolsa de su negocio de Biopharma en Estados Unidos

Related Stories

Luv FM Kel-Charcoal High School Debate Kicks Off

Cleveland Fed's Hammack Expects Multiple Rate Hikes

Nayax Reaffirms 2026 Revenue Guidance, Revises Free Cash Flow

Empresa Distribuidora y Comercializadora Norte Reports Q2 Results

PERSPECTA